Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01011465 · ClinicalTrials.gov registry record · NA

The Biology of Resilience

A NA study, sponsored by Harvard School of Public Health (HSPH).

Completed
Registry status
NA
Development phase
270
Enrollment target

NCT01011465 is a NA study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 270 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01011465, a NA study, has completed, sponsored by Harvard School of Public Health (HSPH).

COMPLETED
Registry status
NA
Development phase
270 participants
Enrollment target

Study Summary

Positive social relationships have consistently been associated with better health, although the neurobiological underpinnings of these observed effects remain largely unknown. The overall goal of the proposed work is to explore novel biological pathways that may explain how social relationships influence health. Recent theorizing suggests that the oxytocin system may underlie some of the observed beneficial effects. Four hypotheses will be examined: 1. Oxytocin ameliorates the deleterious neuroendocrine, cardiovascular, and subjective effects of stress. 2. Oxytocin and social support have similar and additive stress-buffering effects. 3. Effects of oxytocin are evident among younger and older adults. 4. Effects of oxytocin are stronger in women vs men.

Interventions

  • DRUG Placebo
  • DRUG intranasal oxytocin
  • BEHAVIORAL Social support
  • BEHAVIORAL No Social Support

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2009-02
Est. Completion 2012-04
Phase NA

What the Registry Record Tells You About NCT01011465

The ClinicalTrials.gov registry entry for NCT01011465 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT01011465 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01011465 about?

NCT01011465 is a clinical study titled "The Biology of Resilience". Positive social relationships have consistently been associated with better health, although the neurobiological underpinnings of these observed effects remain largely unknown. The overall goal of the proposed work is to explore novel biological pathways that may explain how social relationships inf...

What is the current status of trial NCT01011465?

This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2009-02. Estimated completion is 2012-04.

What interventions are being tested in trial NCT01011465?

The interventions under investigation include: Placebo (DRUG), intranasal oxytocin (DRUG), Social support (BEHAVIORAL), No Social Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT01011465?

This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.